Sandoz Group (SDZNY) News Today $56.61 +0.67 (+1.20%) As of 07/14/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartHeadlinesSEC FilingsShort InterestBuy This Stock SDZNY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Sandoz Group (OTCMKTS:SDZNY) Sets New 12-Month High - Time to Buy?July 14 at 11:10 AM | marketbeat.comSandoz Group AG (SDZNY) - Yahoo FinanceJuly 9, 2025 | finance.yahoo.comSandoz Group (OTCMKTS:SDZNY) Hits New 52-Week High - Here's WhyJuly 7, 2025 | marketbeat.comSDZNY - Sandoz Group AG ADR Dividends - MorningstarJuly 1, 2025 | morningstar.comMSandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High - What's Next?June 30, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Trading Up 1.3% - Here's What HappenedJune 27, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Shares Gap Up - Here's What HappenedJune 18, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Hits New 1-Year High - Time to Buy?June 5, 2025 | marketbeat.comSandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]June 2, 2025 | globenewswire.comSandoz Group (OTCMKTS:SDZNY) Reaches New 1-Year High - Time to Buy?May 31, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Trading 1.6% Higher - Here's WhyMay 26, 2025 | marketbeat.comSandoz Group Ag Regulatory NewsMay 23, 2025 | lse.co.ukSandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilarsMay 21, 2025 | globenewswire.comSandoz Group AG (SDZNY) Q1 2025 Earnings Call TranscriptMay 2, 2025 | seekingalpha.comSandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmedApril 30, 2025 | globenewswire.comSandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indicationsApril 29, 2025 | globenewswire.comSandoz CEO slams EU-wide drug price proposal, warns US tariffs will hurt patient accessApril 28, 2025 | reuters.comRep. George Whitesides Sells Sandoz Group AG (OTCMKTS:SDZNY) StockApril 28, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Shares Down 1.3% - Time to Sell?April 25, 2025 | marketbeat.comSandoz shareholders approve all resolutions at Annual General MeetingApril 16, 2025 | markets.businessinsider.comShareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AGApril 15, 2025 | globenewswire.com[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USApril 14, 2025 | globenewswire.comSwitzerland's Sandoz files antitrust lawsuit against Amgen in USApril 14, 2025 | reuters.comSandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the USApril 14, 2025 | globenewswire.comSandoz price target lowered to CHF 46.50 from CHF 50 at BarclaysApril 3, 2025 | markets.businessinsider.comSandoz Group AG (OTCMKTS:SDZNY) Short Interest UpdateApril 3, 2025 | marketbeat.comSandoz strengthens its balance sheet by issuing new bonds to repay spin-off term loans, and signs new USD 2 billion revolving credit facilityMarch 31, 2025 | globenewswire.comSandoz: Upgrading To A Buy On 2028 ExpectationsMarch 28, 2025 | seekingalpha.comSandoz Group AG (SDZXF)March 28, 2025 | finance.yahoo.comSandoz price target raised to CHF 44 from CHF 42 at RBC CapitalMarch 27, 2025 | markets.businessinsider.comBerenberg Bank Sticks to Their Hold Rating for Sandoz Group Ltd (SDZXF)March 18, 2025 | theglobeandmail.comSandoz Group Ltd (SDZXF) Gets a Buy from Kepler CapitalMarch 18, 2025 | theglobeandmail.comSandoz signs landmark supply and manufacturing agreementMarch 18, 2025 | globenewswire.comSandoz Group AG (OTCMKTS:SDZNY) Sees Significant Decrease in Short InterestMarch 13, 2025 | marketbeat.comSandoz price target lowered to CHF 38 from CHF 41 at Morgan StanleyMarch 12, 2025 | markets.businessinsider.comSandoz Group AG (SDZNY) (Q4 2024) Earnings Call Highlights: Record Sales and Strategic Growth ...March 6, 2025 | gurufocus.comSandoz Group: Sandoz reports strong FY 2024 results and Q4 2024 salesMarch 5, 2025 | finanznachrichten.deSandoz reports strong FY 2024 results and Q4 2024 salesMarch 4, 2025 | globenewswire.comAvecho and Sandoz enter exclusive license and development agreement to commercialise CBD for insomnia in AustraliaMarch 3, 2025 | prnewswire.comSandoz Group AG (OTCMKTS:SDZNY) Short Interest Down 52.6% in FebruaryMarch 2, 2025 | marketbeat.comSandoz Group Ltd (SDZXF) Receives a Hold from UBSFebruary 28, 2025 | markets.businessinsider.comSandoz family foundation offers $3 billion worth of Novartis sharesFebruary 25, 2025 | reuters.comSandoz launches Pyzchiva in the U.S.February 24, 2025 | markets.businessinsider.comSandoz Group: Sandoz launches biosimilar Pyzchiva (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]February 24, 2025 | finanznachrichten.deSandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]February 24, 2025 | globenewswire.comSandoz Group Ltd (SDZXF) Gets a Buy from BarclaysFebruary 18, 2025 | markets.businessinsider.comSandoz price target raised to CHF 41 from CHF 35 at Morgan StanleyFebruary 12, 2025 | markets.businessinsider.comSandoz Group (OTCMKTS:SDZNY) Sets New 52-Week High - Here's WhyFebruary 11, 2025 | marketbeat.comUBS Group Downgrades Sandoz Group (OTCMKTS:SDZNY) to HoldFebruary 6, 2025 | marketbeat.comSandoz Group (OTCMKTS:SDZNY) Sets New 1-Year High - Still a Buy?February 5, 2025 | marketbeat.com Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address SDZNY Media Mentions By Week SDZNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SDZNY News Sentiment▼0.000.99▲Average Medical News Sentiment SDZNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SDZNY Articles This Week▼21▲SDZNY Articles Average Week Get Sandoz Group News Delivered to You Automatically Sign up to receive the latest news and ratings for SDZNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CHGCY News ZTS News TAK News DSNKY News ONC News MKKGY News SMMT News SGIOY News UTHR News NBIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SDZNY) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sandoz Group AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Sandoz Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SDZNY Stock Alerts